Agilent Technologies and CambTEK to Provide Combined Solution for Liquid Chromatography, Sample Preparation
Pharmaceutical, Chemical, Food Science Research Labs to Benefit from Sample Extraction and Preparation Instrumentation and Software
SANTA CLARA, Calif. & CAMBRIDGE, England--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) and CambTEK, Ltd. today announced an agreement to co-market CambTEK’s Rapid Extraction System (RES) automated sample preparation technology with an assortment of Agilent’s liquid phase separation, life science and chemical analysis instruments and software. Used together, these laboratory solutions provide analytical researchers in the pharmaceutical, chemical and food industries with powerful tools to increase the speed and efficiency of laboratory workflows and maximize the quality of their results.
“We are delighted to partner with Agilent to co-market our solutions for the preparation and analysis of solid dosage forms”
“Continuing advancements in analytical technology are enabling faster, more robust analysis capabilities in the laboratory, but work is getting trapped in the bottleneck of the sample preparation workflow,” said Christian Gotenfels, Agilent’s senior product manager for liquid chromatography. “By offering a combined solution for liquid chromatography sample preparation, our complementary technologies will enable analytical researchers to access faster and more robust workflow solutions to achieve higher productivity and data quality.”
CambTEK’s Rapid Extraction System (RES) is a sample preparation instrument designed for rapid extraction of solid dose forms and gels, with important applications in the pharmaceutical, chemical and food science industries. The RES provides enhanced data quality with increased speed and productivity. It is highly versatile and capable of processing a wide range of sample types, including tablets, powders, capsules, gels/pastes, beads, swabs and stents.
“We are delighted to partner with Agilent to co-market our solutions for the preparation and analysis of solid dosage forms,” said CambTEK Chief Executive Officer Dr. Hugh Malkin. “Used together, these technologies will deliver significant benefits to our customers.”
Part of the Cambridge Scientific Innovations group of companies, CambTEK strives to solve real-world problems through innovation and stringent development approaches. CambTEK develops robust automation solutions to reduce inefficiencies and bottlenecks and improve quality of data within key laboratory workflows and applications, improving general R&D and operational capabilities of our clients and positively impacting global healthcare. Information about CambTEK is available at www.cambtek.com.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company’s 20,600 employees serve customers in more than 100 countries. Agilent had revenues of $6.8 billion in fiscal 2013. Information about Agilent is available at www.agilent.com.
On Sept. 19, 2013, Agilent announced plans to separate into two publicly traded companies through a tax-free spinoff of its electronic measurement business. The new company is named Keysight Technologies, Inc. The separation is expected to be completed in early November 2014.
NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available at www.agilent.com/go/news.